181 related articles for article (PubMed ID: 3440638)
21. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
Hultberg B; Ravnskov U
Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750
[TBL] [Abstract][Full Text] [Related]
22. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
23. Enzymuria determination in children treated with aminoglycosides drugs.
Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Seyed-Ebrahimi A; Ghasemi A; Jabari E
Hum Exp Toxicol; 2008 Dec; 27(12):879-82. PubMed ID: 19273542
[TBL] [Abstract][Full Text] [Related]
24. Aminoglycoside nephrotoxicity and urinary excretion of N-acetyl-beta-D-glucosaminidase.
Langhendries JP; Battisti O; Bertrand JM
Biol Neonate; 1988; 53(4):253-9. PubMed ID: 3046671
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
[TBL] [Abstract][Full Text] [Related]
26. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases].
Suzuki M; Asano Y
Rinsho Byori; 1983 Sep; Spec No 56():139-46. PubMed ID: 6663755
[No Abstract] [Full Text] [Related]
27. Renal histological and biochemical changes induced in the rat by dibekacin.
Viotte G; Olier B; Morin JP; Fillastre JP
J Pharmacol Exp Ther; 1983 Jul; 226(1):226-31. PubMed ID: 6864541
[TBL] [Abstract][Full Text] [Related]
28. [Renal tolerance of aztreonam evaluated on the basis of the urinary excretion of N-acetyl-beta-glucosaminidase].
Albertazzi A; Cappelli P; Di Paolo B; Evangelista M
G Ital Chemioter; 1985; 32(2):419-21. PubMed ID: 3833581
[No Abstract] [Full Text] [Related]
29. [Excretion of N-acetyl-beta-glucosaminidase in patients treated with ifosfamide].
Beretta R; Damiani E; Crippa S; Bertolini A; Ottolenghi L; Luchini S
G Ital Chemioter; 1985; 32(1):39-42. PubMed ID: 3830792
[No Abstract] [Full Text] [Related]
30. [Clinical relevance of N-acetylglucosaminidase determination in urine of kidney transplant recipients with and without cyclosporin A].
Loertscher R; Scholer A; Brunner F; Harder F; Thiel G
Schweiz Med Wochenschr; 1982 Nov; 112(46):1658-64. PubMed ID: 6760389
[TBL] [Abstract][Full Text] [Related]
31. [The excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with urinary tract diseases].
Zandvliet EE; Giesberts MA; van Gelderen HH
Tijdschr Kindergeneeskd; 1983 Aug; 51(4):135-8. PubMed ID: 6670088
[TBL] [Abstract][Full Text] [Related]
32. [Effect of antibiotic chemotherapy on urinary N-acetyl-B-D-glucosaminidase activity in patients with chronic pyelonephritis].
Cottone G; Laterza G; Amici A; Gentile V; Perugia G; Russo G; Scibinetti F; Ronchi F; Zappi P; Clemenzia G
Minerva Med; 1986 Oct; 77(38):1717-20. PubMed ID: 3774192
[TBL] [Abstract][Full Text] [Related]
33. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
Crovato E; Salvini R
Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
[TBL] [Abstract][Full Text] [Related]
34. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum.
Diener U; Knoll E; Langer B; Rautenstrauch H; Ratge D; Wisser H
Clin Chim Acta; 1981 May; 112(2):149-57. PubMed ID: 6113066
[TBL] [Abstract][Full Text] [Related]
35. [Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients with urological disease: with special reference to hydronephrosis].
Ueda K; Kato J; Seki T
Hinyokika Kiyo; 1984 Jul; 30(7):877-82. PubMed ID: 6391119
[TBL] [Abstract][Full Text] [Related]
36. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests].
Sano K; Uno E
Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752
[No Abstract] [Full Text] [Related]
37. [Changes in urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) during follow-up period and related factors in diabetic patients].
Arao M; Matsumiya K; Hasegawa K; Horiuchi N; Sasaki A
Rinsho Byori; 1989 Jan; 37(1):37-42. PubMed ID: 2724580
[No Abstract] [Full Text] [Related]
38. Levels of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity versus arterial hypertension.
Laterza G; Clemenzia G; Gentile V; Bassano F; Scibinetti F; Russo G
Panminerva Med; 1984; 26(2):101-3. PubMed ID: 6483455
[No Abstract] [Full Text] [Related]
39. [Urinary excretion of phospholipids: index of aminoglycoside nephrotoxicity].
Olier B; Borsa F; Morin JP; Humbert G; Fillastre JP
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):577-81. PubMed ID: 3534746
[TBL] [Abstract][Full Text] [Related]
40. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 3. Preclinical evaluation of the urinary NAG activity and changes in diabetic patients].
Iimura Y; Shimada I; Ohnuki Y; Kawai T; Sakamoto Y
Rinsho Byori; 1983 Sep; Spec No 56():79-89. PubMed ID: 6663764
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
